Retinal Surface Macrophage Changes in Thyroid Eye Disease before and after Treatment with Teprotumumab
Retinal surface macrophages play key roles in the regulation of immune response, maintenance of vitreous clarity, and tissue repair. We examined the variation of parafoveal surface macrophages in a thyroid eye disease (TED) patient before and after treatment with teprotumumab (Tepezza, Horizon thera...
Saved in:
Main Authors: | Oscar Otero-Marquez, Mona Fayad, Alexander Pinhas, Toco Y. P. Chui, Richard B. Rosen, Harsha S. Reddy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2022/5275309 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patientsResearch in context
by: Yuji Hiromatsu, et al.
Published: (2025-02-01) -
Multimodal Imaging of Waldenstrom Macroglobulinemia-Associated Hyperviscosity-Related Retinopathy Treated with Plasmapheresis
by: Michael J. Schatz, et al.
Published: (2021-01-01) -
Eye Motility Alterations in Retinitis Pigmentosa
by: Raffaele Migliorini, et al.
Published: (2015-01-01) -
Anti‐retinal Autoantibodies in Hydroxychloroquine Eye Toxicity
by: Samuel D. Good, et al.
Published: (2025-01-01) -
Outer Retinal Layers’ Thickness Changes in relation to Age and Choroidal Thickness in Normal Eyes
by: Mona Kamal Abdellatif, et al.
Published: (2019-01-01)